---
schema_version: "secwatch.filing_event.v1"
accession: "0001808220-23-000087"
form_type: "8-K"
ticker: "GOCO"
cik: "0001808220"
company_name: "GoHealth, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:43:15.205323+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoHealth Q2 revenue falls 10% to $142.8M, but Adj EBITDA positive; rejects $20/share bid

## Summary
- Q2 net revenue $142.8M, down 10% YoY from $158.7M; net loss improved to $70.2M from $113.8M.
- Adjusted EBITDA Q2 positive $0.8M vs negative $31.7M prior year; YTD Adj EBITDA $29.6M.
- Submissions grew 5% to 162,837; company exited non-Encompass BPO services in Q2.
- Special Committee rejected $20/share unsolicited buyout proposal from two largest stockholders; says proposal undervalues company.
- Updated FY2023 guidance: net revenue $800-850M, Adj EBITDA $120-140M, cash flow $75-115M, raising lower bounds.

## SEC filing metadata
- accession: 0001808220-23-000087
- form_type: 8-K
- ticker: GOCO
- cik: 0001808220
- company_name: GoHealth, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/0001808220-23-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/goco-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808220-23-000087
- JSON: https://secwatch.observer/filing/0001808220-23-000087.json
- Plain text: https://secwatch.observer/filing/0001808220-23-000087.txt

## Key facts
- Earnings Releases
  GoHealth, Inc. reported the six months ended June 30, 2023 results: revenue $325.9 million, net income net loss of $92.8 million. Guidance raised.
  - Period: the six months ended June 30, 2023
  - Revenue: $325.9 million
  - Net income: net loss of $92.8 million
  - Guidance: raised
  - Result: reported results
  source text: June 30, 2023. Second quarter 2023 net revenues of $142.8 million, a decrease of $15.9 million compared to $158.7 million in the prior year period. YTD 2023 net revenues of $325.9 million, a decrease of $103.3 million compared to $429.2 million in the prior year period. Second quarter 2023 Submissions of 162,837, a 5% improvement compared to 154,893 Submissions in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/0001808220-23-000087-index.htm
- Earnings Releases
  GoHealth, Inc. reported the quarter ended June 30, 2023 results: revenue $142.8 million, net income net loss of $70.2 million. Guidance raised.
  - Period: the quarter ended June 30, 2023
  - Revenue: $142.8 million
  - Net income: net loss of $70.2 million
  - Guidance: raised
  - Result: reported results
  source text: marketplace and Medicare-focused digital health company, today announced financial results for the three and six months ended June 30, 2023. Second quarter 2023 net revenues of $142.8 million, a decrease of $15.9 million compared to $158.7 million in the prior year period. YTD 2023 net revenues of $325.9 million, a decrease of $103.3 million compared to $429.2 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/0001808220-23-000087-index.htm
- Earnings Releases
  GoHealth, Inc. reported Full Year 2023 results: revenue $800 - $850 million. Guidance raised.
  - Period: Full Year 2023
  - Revenue: $800 - $850 million
  - Guidance: raised
  - Result: guidance update
  source text: The Company updates its full year 2023 outlook and expects total net revenue 3 of $800 - $850 million and Adjusted EBITDA 1 of $120 - $140 million, both excluding non-Encompass BPO Services.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/0001808220-23-000087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.